Showing 1 - 19 results of 19 for search 'S. V. Minaeva', query time: 0.03s
Refine Results
-
1
ATHEMATICAL MODEL FOR THE OPTIMISATION OF HIERARCHICAL MULTI-LEVEL PRODUCTION SYSTEMS by Yu. V. Minaeva
Published 2018-12-01
Article -
2
Theory and practice of digital political culture: The views of the French school of communicativistics by T. Yu. Lebedeva, L. V. Minaeva
Published 2023-06-01
Article -
3
-
4
Real-world assessment of treatment multiple myeloma patients on the example of one hematology center by A. S. Luchinin, N. V. Minaeva
Published 2023-10-01
Article -
5
-
6
-
7
-
8
-
9
EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS by A. S. Luchinin, S. V. Semochkin, N. V. Minaeva, N. M. Pozdeev, I. V. Paramonov
Published 2017-10-01
Article -
10
-
11
-
12
Development of Children’s Palliative Care in Perm Krai by Rezeda I. Islamova, Nataliia V. Minaeva, Svetlana P. Baranova, Irina E. Berber, Nataliia V. Dolgomirova
Published 2023-07-01
Article -
13
Mineral potential modelling for gold mineralization within the Mesozoic depressions in the Central Aldan ore-placer region (on the example of the Upper Yakokut ore field) by Vladimir V. Stolyarenko, Alexey V. Minakov, Alexey G. Ryaboshapko, Svetlana V. Minaeva, Valeria A. Alferova
Published 2022-03-01
Article -
14
-
15
-
16
THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS by A. V. Kravchenko, N. V. Sizova, S. V. Minaeva, O. A. Kozyrev, F. I. Nagimova, O. S. Efremova, D. A. Gusev, E. V. Ovsyannikova
Published 2019-03-01
Article -
17
Interrelations between viral load and cellular immunity in patients with COVID-19 of varying severity by Yu. V. Nikitin, E. V. Aleksandrova, A. B. Krivoruchko, M. E. Meshkova, L. V. Minaeva, K. V. Zhdanov, A. A. Artamonov, K. V. Kozlov, A. M. Ivanov, O. V. Maltsev, K. S. Ivanov, Yu. I. Lyashenko, E. B. Masalov
Published 2023-02-01
Article -
18
Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol) by E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Published 2018-10-01
Article -
19
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial by O. A. Aleshina, I. V. Galtseva, E. S. Kotova, G. I. Isinova, T. N. Obukhova, V. N. Dvirnik, A. B. Sudarikov, M. E. Grishunina, O. S. Samoilova, K. D. Kaplanov, V. A. Lapin, S. N. Bondarenko, E. S. Fokina, N. V. Minaeva, T. S. Konstantinova, Yu. V. Sveshnikova, E. E. Zinina, A. S. Antipova, O. Yu. Baranova, E. A. Borisenkova, Yu. O. Davydova, N. M. Kapranov, S. M. Kulikov, Yu. A. Chabaeva, V. V. Troitskaya, E. N. Parovichnikova
Published 2023-03-01
Article